Drug recall · February 27, 2019
Diltiazem HCl Extended-Release Capsules recall
Why: Failed Impurities/Degradation Specifications: High out of specification results obtained during routine stability testing
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Diltiazem HCl Extended-Release Capsules, USP 180mg, Packaged in a) 100-count bottles (NDC 0378-5280-01), and b) 500-count bottles (NDC 0378-5280-05), Rx only, Manufactured by: Mylan Pharmaceuticals Inc. Morgantown, WV, 26505
- Lots / codes
Lot #: 3090167, Exp. October 2019
- Quantity
- 8,159 bottles
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Throughout the United States
- Initiated
- February 13, 2019 · Voluntary: Firm initiated
- Classified
- February 15, 2019
- Reported
- February 27, 2019
- Ended
- September 12, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diltiazem
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.